Evolving guidance and gaps in routine immunization present ongoing challenges for clinicians advocating for vaccine ...

Revised ACC immunization guidance provides evidence-based recommendations for influenza, pneumococcal, COVID-19, RSV, and zoster vaccines.

More than 1 in 10 women (12%) positive for bacterial vaginosis are infected with at least 1 sexually transmitted infection.

Preparation techniques before embryo transfer do not seem to affect pregnancy rates, according to results of a recent review.

Nirsevimab immunization in infants younger than 12 months is associated with a significantly reduced risk for IPD.

Early remdesivir therapy reduces all-cause graft loss and CV event risks in KT recipients with acute symptomatic COVID-19.

For adults with postoperative endophthalmitis, conducting a randomized trial of early vitrectomy vs standard-of-care treatment is feasible.

Prepared foods sold at some stores are being pulled from shelves because the jalapeños they contain may carry Salmonella.

The 2024-2025 US influenza vaccine provided moderate protection against outpatient illness, reducing medically attended visits by one-third.

The FDA approved mFlusiva, the first mRNA-based influenza vaccine, for adults 50 years and older with accelerated approval for those 65 and older.

Delayed antibiotics increase in-hospital mortality only in patients presenting with septic shock, irrespective of immune status.

Tuberculosis risk among patients receiving systemic therapy for dermatologic diseases varied by treatment class and regional burden.